Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

November 30, 2021; 97 (22) Patient Page

Treating Stroke From Inside the Blood Vessel

Time Matters

Steven Karceski
First published November 29, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012920
Steven Karceski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Treating Stroke From Inside the Blood Vessel
Time Matters
Steven Karceski
Neurology Nov 2021, 97 (22) e2250-e2252; DOI: 10.1212/WNL.0000000000012920

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
523

Share

  • Article
  • Info & Disclosures
Loading

Embedded Image

Dr. Sang and associates looked at how well people recovered after treatment for a stroke due to a blockage in the basilar artery. The basilar artery is critical to the brain because it brings blood to deep brain structures like the brainstem, which is important in controlling involuntary body functions such as breathing. The treatment they studied is called endovascular therapy (EVT). More specifically, they looked at time to treatment (which they measured as onset to puncture time [OPT]). In other words, once the stroke had occurred, they looked at the connection between when the treatment was given and how well the person recovered.

How Was the Study Done?

This study was done in China. Forty-seven stroke centers collected information from January 2014 to May 2019. The researchers identified 829 people who had had a basilar artery stroke. Of these, there were 639 patients whose basilar artery stroke was treated with EVT (that is, therapy that is performed inside the affected blood vessel). The study carefully evaluated these patients, looking at 2 endpoints. First, the authors measured how well the person was doing 90 days after the stroke. They used the Rankin Scale, a commonly used scale that measures the degree of disability in people who have had a stroke or who have a neurologic disability. In addition, they looked at the person's functional independence following the stroke.

The authors divided the group into 4 smaller groups. The groups were categorized by the amount of time that had passed between the onset of each person's stroke and the time they had received treatment (in this case, the time to EVT). The treatment groups were those who had treatment less than 4 hours, 4–8 hours, 8–12 hours, and more than 12 hours after stroke. As a control, the researchers compared the group of people with EVT against those who were treated with medicines alone.

What Did They Find?

First, the researchers observed that basilar artery stroke was often very serious: 46% of the patients whose data the researchers studied had died less than 90 days after their stroke. A total of 7.2% of people who had received EVT developed bleeding in the brain (called a hemorrhage) within 48 hours of the therapy. Of the people who had bleeding, the majority were treated with EVT more than 4 hours after their stroke. Those who had EVT less than 4 hours after their stroke were unlikely to develop bleeding in the brain. In other words, a longer time to treatment seems to have correlated with a higher risk of bleeding.

Of the patients who survived their stroke, 32.2% had a favorable outcome, and 27.5% regained functional independence. Those who received treatment more quickly (less than 4 hours after their stroke) had better outcomes overall than those who were treated later (more than 4 hours after their stroke). The researchers found that time was an important factor in the endovascular treatment of basilar artery stroke. The longer it took to get to treatment, the worse a person was likely to do. When the researchers looked at the results, they found there was a point of diminishing returns. There was a loss of the benefits of EVT in people who were treated more than 9 hours after their stroke. However, that does not mean that everyone treated more than 9 hours after their stroke did poorly. Some people who received EVT 9 hours or more after basilar artery stroke did well. These people were more likely to have had a smaller, less debilitating stroke than those who did poorly.

What Does This Mean?

Many trials in stroke treatments have shown that “time is brain.” This means that every minute counts when it comes to stroke treatment. The longer it takes to reach treatment, the greater the degree of neurologic injury is likely to be. In this study, the authors found the same result. In fact, they estimated that the chance of a favorable outcome decreased by 2.3% for every hour treatment was delayed. In addition, the chance of dying as a result of the stroke increased by 2.0% for every hour that the EVT was delayed. In short, the quicker a stroke is diagnosed and treated, the better recovery typically goes, and the more likely the person is to have a greater return of neurologic function.

About Stroke and the Brain

How Does the Brain Work?

For many years, I have tried to think of a way to explain how the brain works. To me, it seems the brain is most akin to an orchestra. There are many parts to an orchestra: percussion, wind instruments, string instruments, et cetera. Each instrument has a part to play in the overall, more complex musical story. When playing together, which requires that the musicians listen to one another, the orchestra can perform complex, beautiful music. The brain is just like this. It is divided into sections like language, movement, and sensation. The difference is that the brain is much more complex than an orchestra. A philharmonic may have 150 members. The brain contains billions of neurons.

Suppose that while the musicians are playing, someone suddenly turned out the lights on one section of the “brain's orchestra.” These players would not be able to see the music they were playing. The rest of the orchestra would continue to play without them. If the section that was no longer playing was “language,” the person would suddenly be unable to speak (or perhaps to understand spoken or written words). This is what happens during a stroke. However, in a stroke, the musician brain cells die, and cannot begin to play again. Since we do not have a way to rejuvenate or regrow brain cells after a stroke, treatments have been aimed at stroke prevention, restoring blood flow to an area of stroke (tissue plasminogen activator [tPA] therapy), and endovascular treatments. Other therapies try to accelerate or improve how the brain recovers function after a stroke. This would be the same as retraining the remaining orchestra members so they could take over the parts that had been played by the lost musicians.

What Is Stroke?

Stroke is a sudden neurologic event.2,3 There are several symptoms common to most strokes. In fact, the American Stroke Association uses a very simple strategy called FAST: F = face drooping, A = arm weakness, S = speech difficulty, and T = time to call 911. There are other signs of stroke such as sudden numbness, sudden confusion, difficulty seeing, or trouble walking. Any of these could be a sign of stroke, but regardless of the symptom, it is always sudden.

What Are the Types of Stroke, and How Are They Treated?

There are 2 main types of stroke: ischemic and hemorrhagic. Ischemic strokes account for about 87% of strokes. Ischemic strokes are usually caused by blood clots that block an artery in the brain. Because blood cannot get past the blockage, neither can oxygen. The brain cells that rely on this oxygen start to have problems, and may die. Time is critical: the longer the cells lack oxygen, the greater number of cells that die.

There are many treatments that are designed to break up the blockage causing the stroke. One of them is tPA; when given intravenously within a short time after the ischemic stroke, tPA dissolves the clot that is blocking the artery. This reopens the blood vessel, restoring blood flow and oxygen to the brain. Another treatment option is EVT. There are several kinds of EVT. All of them approach the clot from within the blood vessel. One type is called mechanical thrombectomy. This is when a medical device is inserted into the affected artery and is sent directly to the clot. It removes the clot, restoring blood flow to the brain. In another type, a device called a stent is placed inside the blood vessel, basically shoving the clot off to the side of the blood vessel so blood flow can resume. The effects of EVT treatments are rapid and can result in a reversal of the neurologic damage.

In the second type of stroke, hemorrhagic stroke, bleeding occurs in the brain. This could be caused by a weak blood vessel or possibly an aneurysm that has ruptured. One of the most common causes of hemorrhagic stroke is poorly managed high blood pressure. The constant high blood pressure puts too much strain on the blood vessels, causing them to burst. Often, surgery is needed to either remove or repair the damaged blood vessel.

Most treatments for stroke are designed to prevent the problem from occurring in the first place. Common causes of stroke include high blood pressure, cigarette smoking, diabetes, obesity, and eating a high-fat diet. Preventing stroke for some people may be a matter of improving their diet: eating healthier foods and avoiding foods that contain high fat or high cholesterol. For others, preventing stroke may include good, consistent control of blood pressure or diabetes. Cigarette smoking should be stopped or be avoided altogether. Physical inactivity is also a risk factor, excluding vigorous activity immediately following stroke. Studies have shown the long-term benefits of exercise over and over again. The bottom line: the more we move and exercise, the healthier we are.

For More Information

Brain & Life

brainandlife.org

American Stroke Association

stroke.org

Brain Aneurysm Foundation

bafound.org

Footnotes

  • Related Article: Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion Page

    Page e2152

  • © 2021 American Academy of Neurology

References

  1. 1.
    1. Sang HF,
    2. Yuan JJ,
    3. Qiu ZM, et al.
    Association between time to endovascular therapy and outcomes in patients with acute basilar artery occlusion. Neurology. 2021;97(22):e2152-e2163.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    American Heart Association web site. Accessed December 2020. heart.org/
  3. 3.↵
    American Stroke Association web site. Accessed December 2020. stroke.org/

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • How Was the Study Done?
    • What Did They Find?
    • What Does This Mean?
    • About Stroke and the Brain
    • How Does the Brain Work?
    • What Is Stroke?
    • What Are the Types of Stroke, and How Are They Treated?
    • For More Information
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder

Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu

► Watch

Related Articles

  • Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion

Topics Discussed

  • Autonomic diseases

Alert Me

  • Alert me when eletters are published
Neurology: 100 (22)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise